Current Alexa Rank
Updated Jan 10 2023
Daily Unique Visitors
Monthly Visitors
Yearly Visitors
Registrar |
MARKMONITOR INC. |
Created |
22.06.2000 |
Updated |
03.09.2013 |
Expiration |
22.06.2014 |
dns1.novartis.com |
dns2.novartis.com |
mia03.digex.com |
IP Address |
217.114.92.50 |
Server Response |
200 |
Web Server |
Microsoft-IIS/8.0 |
- Title
- Choose GLIVECĀ® (imatinib) for KIT+ GIST
- Meta Description
- GLIVECĀ® (imatinib) is indicated for the treatment of unresectable and/or metastatic and adjuvant KIT+ GIST.
- Meta Keywords
- GLIVEC, imatinib, recently resected, adjuvant, metastatic, newly metastatic, progression, KIT+ GIST, gastrointestinal stromal tumour
- Name
- Domain Admin
- Organization
- Novartis AG
- Street
- P.O. Box CH-4002,
- City
- Basel
- Postal Code
- 4002
- Country
- SWITZERLAND
- Phone
- 12083895740
Content-Encoding | gzip |
Cache-Control | private |
Content-Type | text/html; charset=utf-8 |
Server | Microsoft-IIS/8.0 |
Vary | Accept-Encoding |
X-AspNet-Version | 4.0.30319 |
X-AspNetMvc-Version | 5.1 |
X-Powered-By | ASP.NET |